Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2017-001487-38-GB
EUCTR2017-001487-38-GBActive, not recruitingPhase 1

Babies born Early Antibody Response to Men B vaccination: BEAR Men B - BEAR Men B

St George's, University of London0 sites132 target enrollmentStarted: May 9, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
132
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Premature infant born at <35 weeks gestation
  • •No contraindications to vaccination according to the ‘Green Book’
  • •Willing and able to comply with study procedures
  • •Written informed consent
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 132
  • •F.1.2 Adults (18-64 years) no
  • •F.1.2.1 Number of subjects for this age range 0
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

  • •Contraindication to vaccination according to the Green Book
  • •Life-limiting congenital abnormality or condition
  • •Prior diagnosis of an immunodeficiency syndrome
  • •Considered unlikely to complete expected follow up until the end of the study

Investigators

Similar Trials

Completed
Not Applicable
Men B vaccination in preterm infants: a comparison of two schedulesInfections and InfestationsMeningitis
ISRCTN14943533St George's, University of London132
Active, not recruiting
Phase 1
‘Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?women in their first trimester of pregnancy
EUCTR2018-002976-41-NLRIVM120
Completed
Phase 4
*Premature infants and maternal pertussis immunization. Is second trimester vaccination beneficial?*whooping coughpertussis
NL-OMON49737RIVM6,750
Completed
Phase 4
Babies Born Early Antibody Response to Men B Vaccination: BEAR Men BPrematurityVaccinationMeningococcal Disease
NCT03125616St George's, University of London136
Not yet recruiting
Phase 4
A study on the maternal and infant factors determining the performance of Rotavirus vaccines in African, Indian and European infants.
CTRI/2015/11/006354Christian Medical College385